This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Further Evidence Supports Vitamin-D-Deficiency Link to CHD

Posted: Friday, June 20, 2008

Further evidence that vitamin-D deficiency may increase the risk of heart disease has come from a new case-control study.

Investigational DPP-4 Inhibitor Effective as Add-On and Stand-Alone

Posted: Friday, June 20, 2008

Alogliptin, an investigational once-daily oral drug for type 2 diabetes, showed good efficacy and safety both as monotherapy and together with standard agents, researchers in five phase III trials stated at ADA Scientific Sessions.

Glycemic Control Markedly Improved with Duodenal-Jejunal Sleeve

Posted: Friday, June 20, 2008

For obese patients with diabetes, a Teflon-like sleeve placed inside the small intestine just beyond the stomach iimproves glycemic control quickly and markedly.

Diabetic Ulcer Gel Gets Black Box Warning

Posted: Friday, June 20, 2008

A black box warning has been added to the safety labeling for becaplermin gel (Regranex, Johnson & Johnson) to warn of the increased risk for cancer mortality in patients who use 3 or more tubes of the product, the US Food and Drug Administration (FDA) announced on Friday.

Diabetes Prevention Hopes Revived for Thiazolidinedione

Posted: Friday, June 20, 2008

Pioglitazone (Actos) may prevent or delay progression to diabetes for patients with pre-diabetes by 81%, researchers found.

Medicine Might Help Prevent Diabetic Retinopathy

Posted: Friday, June 13, 2008

Diabetics who take the drug rosiglitazone may significantly decrease the chance of visual impairments and blindness. This drug appears to fend off the common and troubling condition known as diabetic retinopathy.

Type 2 Patients Taking Exenatide Once Weekly Improved Glycemic Control, Weight, and Lipid Profiles

Posted: Wednesday, June 11, 2008

Amylin, Eli Lilly and Alkermes announced results from the DURATION-1 trial, a 30-week study that compared the efficacy of exenatide once weekly, a long-acting release formulation of exenatide, to BYETTA(R) (exenatide) injection.

World's largest Trial of Intensive Glucose Control in Type 2 Diabetes Shows Reduced Risk of Complications by 21%: ADVANCE Study

Posted: Wednesday, June 11, 2008

The world's largest diabetes trial has shown intensive blood glucose can reduce the risk of kidney disease by 21% with no evidence of any increased risk of death when blood glucose was intensively controlled.

Parkinson's Cure Might Lay In The Nose

Posted: Saturday, June 07, 2008

Stem cells within the noses of patients suffering from Parkinson's disease might hold the key for a cure to the disease itself. Recent research which harvested these stem cells showed that they were capable of producing an essential, and for Parkinson's patients, lacking, chemical when injected into the brain.

Sprints Improve Blood Vessel Function

Posted: Saturday, June 07, 2008

Short, intensive exercise has been shown to have great benefit for the heart. A primary example of such an activity is sprinting, which was under focus in a study that confirmed this cardiovascular benefit.